Courriel : bd@sidmexinovia.com
Téléphone : +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Adcetris 50mg Injection
Manufacturer/Marketed By : TAKEDA PHARMACEUTICALS INDIA PVT LTD
$2223.30 $1831.89
Adcetris 50mg Injection is an anticancer medication that contains Brentuximab vedotin, a type of CD30-directed monoclonal antibody–drug conjugate (ADC). It is primarily used to treat classical Hodgkin lymphoma, systemic anaplastic...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
BRENTUXIMAB VEDOTIN
Active Pharmaceutical Ingredient
Adcetris 50mg Injection
2 223,30 $US
1 831,89 $US
Adcetris 50mg Injection is an anticancer medication that contains Brentuximab vedotin, a type of CD30-directed monoclonal antibody–drug conjugate (ADC). It is primarily used to treat classical Hodgkin lymphoma, systemic anaplastic large cell lymphoma (sALCL), and cutaneous T-cell lymphoma (CTCL). It may be used as a first-line treatment or when other treatments have not been effective. Adcetris targets a protein called CD30 on cancer cells and delivers a chemotherapy agent (monomethyl auristatin E) directly into them. This targeted approach helps destroy cancer cells while minimising damage to healthy cells. This medicine is given intravenously by a doctor or nurse in a hospital setting. Do not self-administer. The dosage and treatment duration are determined by your doctor based on your condition, body weight, and response to therapy.
Active Pharmaceutical Ingredient
Uses
• Treatment of classical Hodgkin lymphoma
• Treatment of systemic anaplastic large cell lymphoma (sALCL)
• Treatment of cutaneous T-cell lymphoma (CTCL)
Benefits
Adcetris 50mg Injection is used in the treatment of certain types of blood cancers, such as Hodgkin lymphoma and systemic anaplastic large cell lymphoma. It works by specifically targeting cancer cells and delivering a potent anti-cancer agent directly into them, helping to destroy or slow their growth. This targeted action helps reduce damage to healthy cells while effectively controlling the spread of cancer. By improving response to treatment, it can help manage symptoms, slow disease progression, and enhance overall treatment outcomes.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Infusion-related reactions (fever, rash, shortness of breath, chills)
• Allergic reactions
• Inflammation of the pancreas
• Memory loss or confusion
• Blurred vision or difficulty walking
• Unusual bleeding or bruising
• Liver problems (yellowing of skin or eyes, dark urine)
Common Side Effects
• Peripheral neuropathy (tingling, numbness)
• Fatigue
• Nausea
• Diarrhea
• Constipation
• Vomiting
• Fever
• Decreased white blood cell count
• Hair loss
• Weight loss
• Abdominal pain
• Anemia
• Upper respiratory tract infections
• Mouth ulcers (stomatitis)
• Muscle pain
• Itching
How To Use
Adcetris is administered as an IV infusion by a healthcare professional. The treatment is given in cycles, usually once every three weeks. Your doctor may perform regular blood tests to monitor your response and manage any side effects.
Safety Advice
• Breast Feeding: If breastfeeding, consult your doctor before starting the treatment with Adcetris 50mg injection.
• Alcohol: It is unknown whether consuming alcohol interacts with the Adcetris 50mg injection. Please consult your doctor for more advice.
• Liver: Adcetris 50mg injection should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary. Inform your doctor if you have liver issues before initiating the therapy.
• Lungs: It is unknown whether Adcetris 50mg injection is safe for patients with lung problems. Inform your physician if you have lung disease before starting the treatment.
• Driving: Adcetris 50mg injection may be less likely to impair your ability to drive or operate machinery. Consult your doctor for more advice.
• Pregnancy: Adcetris 50mg injection can cause fetal harm to the fetus when administered to pregnant women. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.